Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. - Test2 - elhamkhani - TriplyDB

Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk.

Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk.

http://www.wikidata.org/entity/Q40448724

about

Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?A Co-Inhibitory Alliance in Myeloid Leukemia: TIM-3/Galectin-9 Complex as a New Target for Checkpoint Blockade Therapy.Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer.Trial watch: Immune checkpoint blockers for cancer therapy.PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer.Increased PD-1+ and TIM-3+ TILs during Cetuximab Therapy Inversely Correlate with Response in Head and Neck Cancer Patients.Novel Effector Phenotype of Tim-3 Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer Tim-3 expression and its role in hepatocellular carcinoma

P2860

Q38749824-DDEF31DE-4212-4DDA-981A-3C24CB73FAB3 Q39045550-B78825F9-E0B0-40AE-BCAF-B20D58FA7D19 Q41688447-4F75E7E8-9201-41E9-A71B-1C34989CAF7A Q47134013-A2E4854D-46D7-4918-BDEC-527BA4E9C617 Q47393365-5047AF2A-866D-42CB-877F-16ED47B47358 Q47806987-1E2E96F4-3ADD-4CE2-AD27-EB3C7191419A Q52776942-0DFDE751-3D9C-4BAC-BFE0-C90D333FFC1B Q56888845-C216D15C-C5DD-499C-AD26-9CC50615FE9C Q56956550-559199FB-2CDA-4572-9DAD-95DB46781F10 Q57476217-2508135C-BB5B-4FFB-90F6-4834034AAE56

P2860

Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk.

http://www.wikidata.org/entity/Q40448724

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Tumor-infiltrating Tim-3+ T ce ...... for intracellular cross talk.

@en

type

label

Tumor-infiltrating Tim-3+ T ce ...... for intracellular cross talk.

@en

prefLabel

Tumor-infiltrating Tim-3+ T ce ...... for intracellular cross talk.

@en

P1433

Q40448724-DA104CA3-7FEA-4164-8DD1-30454D0FEBF7

P1476

Q40448724-55D73EF8-3054-4D67-A786-C20855961341

P2093

Q40448724-042F2CF5-8A7E-4502-94B2-74798598B9AB

Q40448724-04691072-0236-457B-9525-9FD68C602744

Q40448724-1BCCF411-C020-4ADC-B65C-1E8F227E6029

Q40448724-3DFA351F-430E-43E2-9D37-4365B4AF45E1

Q40448724-4773D95B-F4D0-4C73-B9DA-2E24D3B8E6F6

Q40448724-56566AF7-7FBE-4275-84B5-541316F14912

Q40448724-6938FCB3-B31D-48BC-B5BD-FF77ADA9F245

Q40448724-7B9FAFD8-1A82-48D1-853C-4305CA935A75

Q40448724-F3C9F689-79D0-4F52-8DCE-C4A81E6687DA

P2860

Q40448724-075BE98C-7235-4997-BA9E-A5B733E5C75C

Q40448724-1156A9E8-D04F-4EAF-9800-F628EB5128C9

Q40448724-1549BC75-374A-45F5-B3E7-32078DD26631

Q40448724-1905A1E5-40E5-4DC7-9F20-DBCA822AF9FD

Q40448724-1D3DA0CD-862A-4FE3-A230-1D55D8F4F8A6

Q40448724-1F0174CB-FE0B-48EF-9771-5A35697B8300

Q40448724-21C2FFEB-3AD2-4665-A2CA-5340624300D0

Q40448724-25D9B38B-C2E0-418D-ACFF-4043F3A98B75

Q40448724-28D467DD-4DAD-44F2-9C86-F65B4A6486B7

Q40448724-30BEF490-EB0A-48A4-8B53-61E82620C596

P304

Q40448724-E497D21A-8AB5-47E6-892D-25B0DFD10F65

P31

Q40448724-F34FDE18-6680-45C9-B18F-0CC9BDEA92AF

P356

Q40448724-06E901A3-EA2E-4C11-84D5-3A72898389C4

P433

Q40448724-097EB2C1-88CF-4736-921D-A85B81553D32

P478

Q40448724-092691E4-EA53-4207-9D64-9607C7C0B483

P577

Q40448724-FA861F8A-5CBF-4146-9A2F-B78655950FDD

P698

Q40448724-EB649510-6CF1-4209-AB1D-86F09164F9E8

P932

Q40448724-992B8B96-4E7A-4E7B-BEB9-DECA45EC866B

P356

2162402X.2016.1200778

P1433

P1476

Tumor-infiltrating Tim-3+ T ce ...... for intracellular cross talk.

@en

P2093

Bin Feng Lu

http://www.w3.org/2001/XMLSchema#string

Gulidanna Shayan

http://www.w3.org/2001/XMLSchema#string

Hyun-Bae Jie

http://www.w3.org/2001/XMLSchema#string

Jing Li

http://www.w3.org/2001/XMLSchema#string

Lawrence P Kane

http://www.w3.org/2001/XMLSchema#string

Lyndsay Avery

http://www.w3.org/2001/XMLSchema#string

Neil Gildener-Leapman

http://www.w3.org/2001/XMLSchema#string

Nicole Schmitt

http://www.w3.org/2001/XMLSchema#string

Robert L Ferris

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Viral immune evasion due to persistence of activated T cells without effector function

Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma

Early T cell signalling is reversibly altered in PD-1+ T lymphocytes infiltrating human tumors

Nivolumab plus ipilimumab in advanced melanoma.

The blockade of immune checkpoints in cancer immunotherapy

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

Coordinated regulation of myeloid cells by tumours

T cell exhaustion

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

P304

e1200778

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2016.1200778

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27853635

http://www.w3.org/2001/XMLSchema#string

P932

5087305

http://www.w3.org/2001/XMLSchema#string